| Literature DB >> 35088107 |
Liang Xiong1,2, Jinyu Huang1,3, Sihui Wang2, Qiong Yuan2, Dongmei Yang2, Zuobing Zheng1, Yangna Wu2, Chunmei Wu1,2, Yanfang Gao1,2, Lijun Zou2, Gonghua Hu4,5.
Abstract
Increasing exploration of rare-earth elements (REEs) has resulted in a high REEs' exposure risk. Owing to their persistence and accumulation of REEs in the environment, their adverse effects have caused widespread concern. However, limited toxicological data are available for the adverse effects of yttrium (Y) and its underlying mechanisms of action. In the present study, H9c2 cardiomyocytes were used in vitro model to investigate the cardiotoxicity of yttrium chloride (YCl3). Results show that YCl3 treatment resulted in reactive oxygen species (ROS) overproduction, decrease in ∆Ψm, and DNA damage. Mechanistically, we detected expression levels of protein in response to cellular DNA damage and antioxidative defense. Results indicated that the phosphorylation of histone H2AX remarkably increased in a dose-dependent manner. At a high YCl3-exposure concentration (120 μM), specific DNA damage sensors ATM/ATR-Chk1/Chk2 were significantly decreased. The protein levels of key antioxidant genes Nrf2/PPARγ/HO-1 were also remarkably inhabited. Additionally, the antioxidant N-acetyl-L-cysteine (NAC) pretreatment promoted the activation of antioxidative defense Nrf2/PPARγ signaling pathways, and prevented the production of cellular ROS, thus protecting the DNA from cleavage. Altogether, our findings suggest that YCl3 can induce DNA damage through causing intracellular ROS overproduction and inhibition of antioxidative defense, leading to cytotoxicity in H9c2 cardiomyocytes.Entities:
Keywords: Cytotoxicity; DNA damage; H9c2 cardiomyocytes; ROS; Yttrium
Mesh:
Substances:
Year: 2022 PMID: 35088107 DOI: 10.1007/s00204-022-03225-1
Source DB: PubMed Journal: Arch Toxicol ISSN: 0340-5761 Impact factor: 5.153